For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Product sourcing reference

Dihexa

Dihexa is a small angiotensin IV analogue studied in animal models of cognition. It has not been evaluated in controlled human trials.

Reference variants

Add Dihexa to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

  • 10mgVial · confirm physical formCAS 1401708-83-5
    $31.63/vial$25.30/vial at 1,000+ vials of this item
    vials, packs of 10

Review your order request · Compare the full catalog

Confirm the exact substance

Dihexa is a modified peptide-like small molecule. Treat its specification as a chemical compound and confirm identity with structural data.

What the review will ask

Cognitive claims originate from preclinical research. A request should describe intended use and should not rely on enhancement claims.

  • State the facility type, destination state and intended transaction. Do not send patient information.
  • Expect product- and lot-specific documentation to be requested before any material is accepted.
  • A listed price is a reference estimate. Availability, labeling, shipping and terms are confirmed in writing only after review.

Purchasing questions

Has dihexa been tested in humans?

We are not aware of published controlled human trials. Evidence is preclinical.

Check whether the document concerns the acetate

FDA specifically discusses dihexa acetate and reports no identified human exposure data for drug products containing it. A generic Dihexa label leaves the exact form unresolved.

Documentation to request

Obtain the chemical structure, salt or counter-ion and analytical identity report for the quoted material before reviewing any cognition claim.

Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Non-clinical protocol review checklist. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. This reference is not medical or legal advice and does not establish a lawful supply route.

Discuss sourcing requirements
Call Apply for Wholesale